| Sep 18 |
Why ResMed's Rally Is Just Getting Started
|
| Sep 18 |
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.
|
| Sep 18 |
We Think ResMed (NYSE:RMD) Might Have The DNA Of A Multi-Bagger
|
| Sep 16 |
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
|
| Sep 13 |
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
| Sep 12 |
ResMed (NYSE:RMD) stock performs better than its underlying earnings growth over last five years
|
| Sep 11 |
Reasons to Retain ResMed Stock in Your Portfolio for Now
|
| Sep 10 |
ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange
|
| Sep 10 |
Vaping Expected to Increase COPD Health and Economic Burden by 2050
|
| Sep 9 |
Here's How Much You Would Have Made Owning ResMed Stock In The Last 15 Years
|
